Master the litigation strategies that your
company needs to successfully scale the legal intricacies of this next crag of
the patent cliff.

It is estimated that the industry will experience patent
losses approaching $150 billion within the next three years.* This will
undoubtedly test the balance of power created by the Hatch-Waxman Act and lead
to dramatic new litigation challenges for brand names and generics.

Come to this conference and meet with the
leading legal minds in this area as you acquire the skills needed for the new
era of extreme Hatch-Waxman litigation.

Now in its eighth iteration, American Conference Institute’s (ACI’s) Paragraph IV Disputes conference is the only event which helps both
brand name and generic pharmaceutical companies make sense of changing industry
dynamics precipitated by the patent cliff and other factors such as patent
reform, regulatory shifts and recent and pending case law. This is the
conference that not only sets the standards for Paragraph IV litigation, but
also serves as the annual meeting place for the “who’s who” of pharmaceutical
patent litigation.

With the help and input of ACI’s Hatch-Waxman Advisory
Board, we have designed this conference as a true symposium. At this gathering, there will be in-depth
discussions and practical take-aways that will prepare you for this new era of
extreme Hatch-Waxman litigation. Critical sessions will address all facets of
Paragraph IV litigation from pre-litigation concerns to the commencement of
suit through final adjudication. Most
importantly, our faculty will delve deeply into the re-shaping of these
elements by an evolving legal, regulatory, and procedural schematic and the
harsh economic realities of the patent cliff.

Meet with our faculty of leading counsel from well-known
companies and lawyers from firms who represent both brand name and generic
interests as they join together to discuss and provide insights on:

·Paragraph IV assertions of invalidity and non
infringement in view of changes to the U.S. patent system under the AIA

·PTO proceedings as a parallel or alternate path in a Paragraph
IV challenge

·New obviousness challenges based on evolving
case law and patent reform

·Evolving theories of law in divided infringement
and inducement that are influencing method of treatment claims

·Damages and at risk launches in view of Protonix

·Inequitable conduct challenges post- Therasense
and post-AIA

Our prior
delegates say it best:

·“ACI’s Paragraph IV Disputes (NYC) is the
premiere conference in our industry – the place to see and be seen and to rub
shoulders with all colleagues, clients and the major players in Hatch- Waxman
litigation.” (2013 attendee)

·“Overall good information and discussed issues
of relevance for the present and speakers projected thoughts on future trends
which [was] informative and useful.” (2013 attendee)
“A tremendous amount of valuable information.
The speakers were knowledgeable, dynamic, and engaging.” (2013 attendee)

·“This outstanding program has become even
better! It is an invaluable resource for
anyone who practices in this complex demanding field, with a timely,
comprehensive agenda and impressive presenters who are at the top of the
profession.” (2012 attendee)

·“Useful and informative.” (2012 attendee)

·“Excellent.”
(2012 attendee)

·“It is a very interesting conference. Best when attorneys for generics and branded
comment on an issue to get opposing views.” (2012 attendee)

·“Very good conference! Presenters that discussed as a team [were]
very effective.” (2011 attendee)

·“Exceptional.
Incredibly talented speakers.
Presenters know their stuff cold … and are real experts. [These are] the people who are making
law.” (2012 attendee)

·“Really great program – very timely and
topical. All of the speakers have been
superb.” (2011 attendee)

You must acquire and master the necessary skills to rise to the
challenges of this costly and ruthless endgame Past iterations of this
event have sold out; register now to ensure your place at this unique and
important event. Call 1-888-224-2480, fax your registration form to
1-877-927-1563 or log onto www.americanconference.com/PIVDisputesNYC.

Full conference details are on the way shortly. If you are interested in speaking at this
event, contact Lisa Piccolo at l.piccolo@americanconference.com. For information on sponsoring or exhibiting
at this event, contact Esther Fleischhacker a ef@americanconference.com.